newsfilter
← Latest News
GlobeNewswire·

Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering

RICHMOND, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced the pricing of an underwritten offering consisting of 35,190,292 shares of its